Clinical Study

Psychometric Testing of the CHAMPS Questionnaire in French Canadians with COPD

Table 5

Correlations of CHAMPS caloric expenditure scores with measures of health-related quality of life (HRQoL).

HRQoL measureDomainAll activitiesModerate-intensity activities
English-speaking participants (N = 56)French-speaking participants (N = 74)English-speaking participants (N = 56)French-speaking participants (N = 74)

SF-36GH0.007 (−0.3, 0.3)0.1 (−0.1, 0.3)0.3 (0.04, 0.5)§0.2 (−0.03, 0.4)
RP0.3 (0.04, 0.5)§0.2 (−0.03, 0.4)0.2 (−0.07, 0.4)0.3 (0.08, 0.5)§
PF0.2 (−0.07, 0.4)0.2 (−0.03, 0.4)0.3 (0.04, 0.5)§0.5 (0.3, 0.7)§
BP−0.2 (−0.4, 0.07)0.05 (−0.2, 0.3)0.03 (−0.2, 0.3)0.05 (−0.2, 0.3)
MH−0.02 (−0.3, 0.2)0.2 (−0.03, 0.4)0.02 (−0.2, 0.3)0.3 (0.08, 0.5)§
RE0.09 (−0.2, 0.3)0.2 (−0.03, 0.4)0.1 (−0.2, 0.4)0.3 (0.08, 0.5)§
SF0.2 (−0.07, 0.4)0.2 (−0.03, 0.4)0.3 (0.04, 0.5)§0.4 (0.2, 0.6)§
VT0.2 (−0.07, 0.4)0.04 (−0.2, 0.3)0.4 (0.2, 0.6)§0.3 (0.08, 0.5)§
PCS0.2 (−0.07, 0.4)0.06 (−0.2, 0.3)0.4 (0.2, 0.6)§0.2 (−0.04, 0.4)
MCS0.06 (−0.2, 0.3)0.2 (−0.04, 0.4)0.1 (−0.2, 0.4)0.3 (0.07, 0.5)
SGRQActivity−0.2 (−0.4, 0.07)0.3 (−0.5, −0.08)§−0.5 (−0.7, −0.3)§−0.5 (−0.7, −0.3)§
Symptoms0.08 (−0.2, 0.3)−0.02 (−0.3, 0.2)−0.1 (−0.4, 0.2)−0.2 (−0.4, 0.03)
Impact0.02 (−0.2, 0.3)−0.2 (−0.4, 0.03)−0.3 (−0.5, −0.04)§−0.3 (−0.5, −0.08)§
Total−0.05 (−0.3, 0.2)−0.2 (−0.4, 0.03)−0.4 (−0.6, −0.2)§−0.4 (−0.6, −0.2)§

Spearman’s Rho and 95% confidence intervals. English-speaking participants: N = 55 SF-36 physical component summary. French-speaking participants: N = 73 SF-36 physical functioning; N = 70 physical component summary. §Statistically significant correlations (95% CI does not include zero; ). Those in bold met the threshold for moderate correlation (r ≥ 0.4).